Medical Fluid Bags Market Size By Product (Blood Bags, Intravenous Bags, Drain Bags {Surgical, Urinary}, Enema Bags, Biohazard Disposable Bags, Breast Milk Bags, Reagent Bags, Dialysis Bags), By Material (PVC Compounds, Polyolefins, Thermoplastic Elastomers, Thermoplastic Polyurethanes), By End-Use (Hospitals, Blood Banks, Clinics, Homecare Settings, Diagnostic Centers), COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Aug 2021  |  Report ID: GMI1677  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 250   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Medical Fluid Bags Market size was valued at USD 3.2 billion in 2020 and is expected to grow at a CAGR of over 6.4% between 2021 and 2027. Growing incidence of chronic diseases and expanding geriatric population base are among the key factors facilitating the market growth. Rise in number of preterm births will also amplify the market expansion in the coming years. Biohazard disposable bags and intravenous bags find extensive application in hospitals and birth centers.
 

Medical Fluid Bags Market Overview

Get more details on this report - Request Free Sample PDF
 

However, complications associated with the use of PVC-composed medical fluid bags on patient health and concerns regarding improper disposal causing detrimental impact on the environment may negatively affect the market progression. According to the National Centers for Biotechnology Information (NCBI), prolonged exposure to endocrine-damaging bisphenol-A (BPA) and di-(2-ethylhexyl) phthalate (DEHP) are associated with serious health ailments.
 

Several epidemiological studies and clinical experiments related to side effects of BPA and DEHP have stated destructive effects on reproduction and health such as decreased male fertility, early sexual maturation, aggressive behaviour and others. Moreover, the U.S. FDA regulates the development, approval and post-approval surveillance of medical devices including medical fluid bags. Majority of the medical fluid bags are classified as Class I medical devices that mandates the manufacturers to register their establishment. Medical fluid bags are also required to feature accurate labels and meet the packaging standard requirements of 21 CFR 175.105 for getting the FDA approval. The mandatory regulatory compliance might delay the product commercialization that may restrain the medical fluid bags market demand.
 

The COVID-19 pandemic influenced the medical fluid bags market slightly in the initial phase. The coronavirus outbreak impacted several sectors of the economy by inflicting economic damage and increasing disease burden across many countries. Several sectors have experienced the drastic impact of the outbreak causing financial adversities and healthcare sector was at the forefront. Factors such as supply chain disturbances, delay in raw material shipments have affected the industry expansion.
 

The WHO published interim guidelines in March 2020 that suggested providing intravenous fluid therapy to the infected and critical COVID-19 patients. Similarly, the guidelines published by the UK Joint Anaesthetic and Intensive Care & International Fluid Academy also recommended providing critical patients fluid therapy to meet their fluid and electrolyte requirements. Such guidelines will increase the demand for intravenous bags used in IV therapy, ultimately leading to the medical fluid bags market revenue. Additionally, the European Society for Clinical Nutrition and Metabolism (ESPEN) is pushing the use of enteral and parenteral nutrition for maintaining the daily nutritional requirements of the COVID-19 patients. However, the cancellation of elective surgeries, allotment of a significant percent of healthcare resources dedicated for COVID-19 have resulted in a decline of total admissions, thereby hampering the industry demand.
 

Growing incidence of chronic diseases is set to flourish the medical fluid bags market value

Increasing prevalence of chronic disorders is anticipated to surge the need for medical fluid bags. Significant proportion of the population across the world are suffering from chronic diseases such as cancer, kidney disorders, gastrointestinal diseases and others. According to the Centres for Disease Control and Prevention (CDC), approximately 9.5% of the U.S. adults are detected with cancer and result in around 600,000 mortalities annually. The number of cancer patients is further projected to soar in the coming years. Similarly, the incidence of kidney associated disorders such as acute kidney injury, chronic kidney disease and end-stage renal disease is on rise.
 

The prevalence of chronic kidney disease is approximately 14% in the U.S. with over 661,000 Americans suffering from kidney failure. Among these, around 468,000 adults require dialysis. Dialysis bags are increasingly used in the management of kidney failure to collect bodily fluids including blood. These bags also find application in cancer therapeutics, especially in chemotherapy patients and are used to provide nutritional supplements and medications through intravenous mode to the patients. In addition, in case of gastrointestinal diseases, medical bags are used to provide clinical nutrition, essential fluids, electrolytes and liquid medications to the patient in order to prevent dehydration and ensure quick recovery.
 

Increasing number of initiatives taken by public and private organizations to promote blood donations is slated to boost the use of blood bags

The blood bags segment in the medical fluid bags market accounted for USD 343 million in 2020 led by the growing number of blood donations and initiatives taken by governments & private organizations to promote blood donations across the globe. For instance, the Chinese government accepted the voluntary non-remunerated donation concept, implemented several mandates for efficient blood transfusion, and incorporated latest blood testing technology to ensure optimum blood supply. 
 

The blood donors in China surged by 275% from 1998 to 2018 (from 4 million to 15 million). Similarly, the Facebook launched Blood Donations feature in countries such as South Africa, Senegal, Egypt, the U.S., India and Brazil among others. This feature helped the blood donation centers in India and Brazil, thereby promoting the medical fluid bags market expansion. Surveys revealed that this initiative launched by Facebook influenced 20% of people to donate blood. Blood bags are extensively used for collection, classification, storage and transport of blood in the blood centers.
 

Numerous advantages offered by the use of PVC medical fluid bags will foster the industry growth

The medical fluid bags market for PVC compounds segment is poised to reach USD 1.16 billion by 2027 impelled by the host of benefits offered by the fluid bags composed of PVC compounds. The PVC medical bags are easy to handle, steam sterilizable and most importantly affordable in comparison to other choices. These bags are highly preferred in collection and storage of blood & blood components as these bags assure 42 days of shelf life that is crucial for storage of rare blood types. PVC blood bags enable highest sterilisation techniques and allow freezing if required. Moreover, two of the PVCMed Alliance’s member companies have developed phthalate DEHP-free PVC blood bags that meet the high standard requirements for blood collection & storage. The development of DEHP-free medical bags will increase acceptance rate of PVC medical bags.
 

Rising number of hospitalizations owing to diarrheal diseases is anticipated to drive the segment growth

Medical Fluid Bags Market Size

Get more details on this report - Request Free Sample PDF
 

The hospitals segment in the medical fluid bags market exceeded USD 1.10 billion in 2020 due to the increasing hospitalizations and surging incidence of diarrheal diseases. As per the PLOS Neglected Tropical Diseases, the estimates highlight that 66,400 to 249,000 children are predicted to be hospitalized and reporting for 5,800 to 14,600 deaths attributed to diarrhoea in India, every year. According to the WHO, approximately 1.7 billion children aged below 5 years suffer from diarrheal disease, accounting for 525,000 mortalities in children annually. The number is significantly higher in the developing countries, especially in the African and South Asian countries.
 

Increased hospital visits and growing surgical volume in the North America region will amplify the regional growth

Global Medical Fluid Bags Market

Get more details on this report - Request Free Sample PDF
 

U.S. dominated the North America medical fluid bags market and will capture over USD 1.14 billion by 2027 on account of the increased hospital visits and growing surgical volume across the country. According to the Healthcare Cost and Utilization Project statistics, approximately 17.2 million hospital visits were reported in ambulatory surgical centers as well as hospitals for invasive and therapeutic surgeries across the U.S. The National Center for Health Statistics data showcases that around 48 million inpatient surgeries were carried out in the U.S. The increasing number of surgical procedures is set to prove beneficial for medical fluid bags as these bags form an integral part of surgical essentials and used in draining the bodily fluids, providing liquid medications, nutrition, electrolytes and blood to the patient.
 

Germany held majority of revenue share in the Europe medical fluid bags market and is projected to cross USD 263 million by 2027 owing to the growing geriatric population and rising prevalence of chronic diseases across the country. According to the Globocan (Global Cancer Observatory), in 2020, around 628,519 people in the country were reported to be diagnosed with cancer and it is further estimated to grow in the coming years. According to the German Kidney Foundation, approximately 5 to 6 million people in Germany suffer due to impaired kidney function. Whereas, approximately 80,000 patients are currently undergoing long-term dialysis treatment in the country. The Robert Koch Institute highlights that the chronic kidney disease tends to affect 1 in every 8 individuals aged between 70 and 79. The high proportion of population suffering from chronic kidney disorders and cancer coupled with surging geriatric population is expected to augment the usage of medical fluid bags in healthcare settings.
 

Strategies implemented by prominent players will surge the industry progression

Some of the major companies operating in the medical fluid bags market are B. Braun Medical, Baxter International, C.R. Bard (Becton, Dickinson and Company), Coloplast, ConvaTec, Fresenius Kabi, Maco Pharma, Pall Corporation, Renolit, Smiths Medical, Technoflex, Terumo Corporation and Thermo Fisher Scientific among others. These prominent participants emphasize on adopting strategic initiatives such as acquisitions, new product launches, partnerships, and geographical expansion for business development. Furthermore, these leaders are substantially investing in research that allows them to launch advanced products and generate maximum revenue in the medical fluid bags market.
 

Recent industry developments:

  • In November 2020, Fagron Sterile Services (FSS) announced the launch of Intravenous (IV) Bags and extended the pre-existing product line of fentaNYL, HYDROmorphone, and midazolam brands. This launch helped the company to strengthen its product portfolio and enhance the product sales.
     
  • In May 2019, B Braun announced USD 1 billion investment in manufacturing facilities to ensure consistent supply of intravenous products. The investments consist of advanced manufacturing facility in Florida, and upgradation of existing facilities. This investment helped them in scaling-up the production of IV products in the U.S.
     

Medical fluid bags market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Kilotons from 2016 to 2027, for the following segments:

Market, By Product, 2016 - 2027 (USD Million and Kilotons)

  • Blood Bags
  • Intravenous Bags
  • Drain Bags
    • Surgical
    • Urinary
  • Enema Bags
  • Biohazard Disposable Bags
  • Breast Milk Bags
  • Reagent Bags
  • Dialysis Bags
  • Others

Market, By Material, 2016 - 2027 (USD Million and Kilotons)

  • PVC Compounds
  • Polyolefins
  • Thermoplastic Elastomers
  • Thermoplastic Polyurethanes          
  • Others

Market, By End-use, 2016 - 2027 (USD Million and Kilotons)

  • Hospital
  • Blood Banks
  • Clinics
  • Homecare Settings
  • Diagnostic Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • EuropeGermany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea 
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
       

Frequently Asked Questions (FAQ) :

Market size of medical fluids exceeded USD 3.2 billion in 2020 and will expand at a CAGR of 6.4% from 2021 to 2027.
Market revenue from blood bags was recorded at recorded USD 343 million in 2020 and will grow with surging number of blood donations and initiatives taken by governments and private organizations.
PVC compounds will register USD 1.16 billion valuation by 2027 as they are steam sterilizable, easy to handle, and more affordable than other choices.
U.S. market will record USD 1.14 billion through 2027 owing to the increased hospital visits and the rising surgical volume across the country.

Premium Report Details

  • Published Date: Aug 2021
  • Pages: 250
  • Tables: 498
  • Charts / Figures: 15
  • Companies covered: 16
  • Countries covered: 18

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X